Skip to main content

Table 1 Results of immunological evaluation*

From: X-linked agammaglobulinemia diagnosed late in life: case report and review of the literature

  Patient 1 Patient 2
Age 64 46
WBC (cells/uL) 8.3 (3.2–9.8) 6.9 (5.0–10.2)
Granulocytes (%) 59 (42–75) 68 (45–75)
Lymphocytes (%) 28 (20–51) 18 (20–50)
Monocytes (%) 9.5 (0–12) 12 (0–8)
IgM (mg/dL) 25 95 (50–300)
IgG (mg/dL) 360 260 (565–1765)
IgA (mg/dL) 27 16 (40–350)
C3 (mg/dL) ND 129 (85–200)
C4 (mg/dL) ND 23 (14–53)
CH50 (U/ml) ND 51 (22–60)
CD4+ (cells/uL) 1023 (720–1440) 624 (575–1070)
CD8+ (cells/uL) 979 (315–788) 477 (190–860)
NK (cells/uL) ND 135 (150–880)
CD19+ (cells/uL) 0 (113–495) 0 (70–300)
SPEP Hypogammaglobulinemia Hypogammaglobulinemia
Pneumococcal responses Impaired Impaired
  1. Abbreviations: SPEP, serum protein electrophoresis; WBC, white blood cells; NK, natural killer;
  2. * Values in parentheses represent reference ranges